Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment
Clinical trial NCT06497465 · RECRUITING
Trial details
- NCT number
- NCT06497465
- Sponsor
- Johns Hopkins University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-18
- Primary completion
- 2028-01-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.